Mandate

Vinge advises Active Biotech on directed new share issue

April 06, 2010

The biotechnology company, Active Biotech (NASDAQ OMX Stockholm) is carrying out a directed new issue of shares for approximately SEK 149 million to funds managed by Sectoral Asset Management Inc. Vinge is acting for Active Biotech.

Vinge’s team consists of Erik Sjöman and Christian Lindhé.

Related

Vinge advised Dr Schär

Vinge advised Dr Schär in the acquisition of Semper AB:s glutenfree business Dr. Schär, an Italian based company, is a developer of product for special nutritional needs.
February 29, 2024

Vinge advises Irisity AB in connection with the acquisition of Ultinous and a directed share issue

Vinge advises Irisity AB in connection with the acquisition of Ultinous and a directed share issue
February 29, 2024

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with SBB establishing a joint venture company for community properties together with Castlelake, LP ("Castlelake").

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) ("SBB") in connection with SBB establishing a joint venture company for community properties together with Castlelake, LP ("Castlelake").
February 29, 2024